Literature DB >> 16863434

Evaluation of neurotoxic potential by use of in vitro systems.

Gaylia Jean Harry1, Evelyn Tiffany-Castiglioni.   

Abstract

In vitro systems have been proposed, but not yet demonstrated, as a method to assess the neurotoxicity of compounds in an efficient and rapid manner. Although such tests are desired both for pharmaceuticals and environmental agents, such a battery has yet to be developed that is based on known processes of nervous system dysfunction. In this review article, characteristics and potential limitations associated with in vitro methods are discussed. Many of these features have been identified from a larger body of work examining the neurotoxicity of environmental agents and the mechanisms underlying activity of known neurotoxicants. These issues include relevant drug concentrations, factors that limit or alter drug accessibility to the nervous system, and the need for assays to reflect biologically meaningful end points. This commentary briefly surveys in vitro systems of increasing biological complexity currently available for toxicity testing, from single cell types to systems that preserve some aspects of tissue structure and function. A small number of studies to evaluate drugs for cytotoxicity and biological responses in vitro are presented as representative of the current state of the field and to provide a reference and direction for additional development of methods to assess a compound's potential for neurotoxicity.

Entities:  

Mesh:

Year:  2005        PMID: 16863434     DOI: 10.1517/17425255.1.4.701

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  8 in total

1.  Evaluation of the importance of astrocytes when screening for acute toxicity in neuronal cell systems.

Authors:  E K Woehrling; E J Hill; M D Coleman
Journal:  Neurotox Res       Date:  2009-07-11       Impact factor: 3.911

2.  A neuronal and astrocyte co-culture assay for high content analysis of neurotoxicity.

Authors:  Janet L Anderl; Stella Redpath; Andrew J Ball
Journal:  J Vis Exp       Date:  2009-05-05       Impact factor: 1.355

Review 3.  Modeling chemotherapy induced peripheral neuropathy (CIPN) in vitro: Prospects and limitations.

Authors:  Helmar C Lehmann; Nathan P Staff; Ahmet Hoke
Journal:  Exp Neurol       Date:  2019-12-05       Impact factor: 5.330

4.  MicroRNAs in Neurotoxicity.

Authors:  Prameet Kaur; Arunmozhiarasi Armugam; Kandiah Jeyaseelan
Journal:  J Toxicol       Date:  2012-03-06

5.  Prediction of the dose range for adverse neurological effects of amiodarone in patients from an in vitro toxicity test by in vitro-in vivo extrapolation.

Authors:  Engi Abd El-Hady Algharably; Emma Di Consiglio; Emanuela Testai; Reinhold Kreutz; Ursula Gundert-Remy
Journal:  Arch Toxicol       Date:  2021-02-19       Impact factor: 5.153

Review 6.  Roadbumps at the Crossroads of Integrating Behavioral and In Vitro Approaches for Neurotoxicity Assessment.

Authors:  G Jean Harry; Sandra McBride; Shannah K Witchey; Sakina Mhaouty-Kodja; Alain Trembleau; Matthew Bridge; Anna Bencsik
Journal:  Front Toxicol       Date:  2022-02-25

Review 7.  The Therapeutic Potential of Carnosine as an Antidote against Drug-Induced Cardiotoxicity and Neurotoxicity: Focus on Nrf2 Pathway.

Authors:  Giuseppe Caruso; Anna Privitera; Barbara Moura Antunes; Giuseppe Lazzarino; Susan Marie Lunte; Giancarlo Aldini; Filippo Caraci
Journal:  Molecules       Date:  2022-07-12       Impact factor: 4.927

Review 8.  Magnetic nanoparticles for theragnostics.

Authors:  Veronica I Shubayev; Thomas R Pisanic; Sungho Jin
Journal:  Adv Drug Deliv Rev       Date:  2009-04-20       Impact factor: 15.470

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.